Results from the ongoing MarkVCID consortium also indicate that in individuals at risk for cognitive impairment and dementia, PlGF may function as a candidate biomarker measuring the severity of vascular injury and WMH lesion burden and may serve as an accurate cross-sectional diagnostic biomarker and contribute as a prognostic susceptibility biomarker longitudinally [125]. This evidence concerns the gene PGF and dementia.